Shown to reduce food intake, nesfatin-1 has an inhibitory effect on food intake and thus alleviates obesity in a dose- and time-dependent manner upon intracerebroventricular and intraperitoneal injection, as well as after intranasal administration [14]. The gene discussed is NUCB2; the disease is obesity due to melanocortin 4 receptor deficiency.